Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity PressReach · Jul 15, 2025
Englobe completes transaction to acquire Ontario-based engineering firm Cambium PressReach · Jul 14, 2025
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing PressReach · Jul 14, 2025
Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform PressReach · Jul 14, 2025
Master Injector Alexander Tirado Brings Passion and Knowledge as New Wellness Director at Parkland Medspa and Wellness Center PressReach · Jul 12, 2025
Strive Compounding Pharmacy Hosts "Dinner with the Doc" Initiative, Offering Insight into Personalized Medicine PressReach · Jul 12, 2025
Truth Initiative Backs Arizona AG in Bold Action to Protect Youth from Illegal Nicotine Sales PressReach · Jul 12, 2025
Movano Health Plans to Timely Request a Hearing Before a Nasdaq Hearings Panel PressReach · Jul 12, 2025
Trulieve Partners with Redemption Cannabis to Launch Purpose Led Products in West Virginia PressReach · Jul 12, 2025
